Researchers from Teesside University and the National Institute for Health and Care Research (NIHR) Applied Research ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

The extent of skin involvement and the severity of symptoms determine the stage, which helps guide the choice of treatment. Moderate psoriasis affects about 3% to 10% of the body surface and ...

While hyperpigmentation is harmless, it can be cosmetically bothersome for many people and impact their self-esteem. Fortunately, several effective treatments can help decrease melanin production and ...

Overall, the pathogenesis and treatment of PRISm have significant knowledge gaps, according to the committee. “Not all individuals with pre-COPD or PRISm will eventually develop fixed airflow ...

To the Editor: In the Undiagnosed COPD and Asthma Population (UCAP) trial, Aaron et al. (June 13 issue) 1 used an automated telephone service to contact more than a million persons living near one ...

The treatment you receive for sickle cell disease will depend on your specific symptoms. Possible treatments include blood transfusions, medications such as hydroxyurea, and emerging therapies.

They are more frequently found in girls than boys. Head lice live in all types of hair, whether it’s curly, straight, dyed or natural. Before you start treatment, understand how your child could have ...

DirectRx, a specialty pharmacy for people with chronic health disorders, is now part of the exclusive U.S. pharmacy network distributing Ohtuvayre (ensifentrine), a newly approved therapy for chronic ...

While artificial intelligence (AI) promises to transform all manner of industries, the biggest game-changing breakthroughs in this new era of data-infused machine intelligence arguably lies in the ...

AstraZeneca executives say they are “not worried” that the failure of tozorakimab in a phase 2 chronic obstructive pulmonary disease (COPD) trial will throw their plans for the anti-IL-33 ...